
Julia C. Owens, Ph.D.

Dr. Julia C. Owens is a seasoned biopharmaceutical executive and board member with over 25 years of experience, who currently works with multiple biotech companies and venture capital firms. She is founding CEO of Verto Therapeutics, an early-stage drug discovery company. She is also Chairman of Sena Therapeutics, a women’s health company, and an advisor to GV (Google Ventures), specializing in women’s health investments. Additionally, she is a board member for EVOQ Therapeutics and the Biotechnology Innovation Organization (BIO). She serves on the Leadership Council of the University of Michigan Life Sciences Institute and the Investment Advisory Board of the Michigan Biomedical Venture Fund.
​
​Her previous roles include CEO of Ananke Therapeutics and nearly a decade as founder and CEO of Millendo Therapeutics (NASDAQ: MLND). Earlier in her career, she held senior roles in business and corporate development at Tularik Inc., QuatRx Pharmaceuticals, and Lycera Corp.. Dr. Owens holds a Ph.D. from the University of California, San Francisco, and a B.S. in Chemistry and B.A. in Molecular and Cellular Biology from the University of California, Berkeley. Dedicated to empowering female leadership, Dr. Owens co-founded the Biotech CEO Sisterhood to support and advance women in the biotech sector.
About the Sisterhood
The Biotech CEO Sisterhood is a vibrant community dedicated to championing the success of women leaders in the biopharma industry. Rooted in a culture of mutual support and authenticity, the Sisterhood aims to inspire and uplift women while driving meaningful conversations and impact across the industry. As part of our commitment to nurturing the current and future generations of biotech leaders, the Sisterhood hosts summits, local events, and educational sessions. These programs encourage dialogue about the challenges facing women in biotech, share best practices, and enhance leadership effectiveness. Since its inception in 2022, the Biotech CEO Sisterhood has grown to 300+ members. To follow our progress and learn more, please follow us on LinkedIn.
Follow BiotechTV
Also look for unique social pages for BiotechTV U.
Sponsor Spotlight
Evaluate is a trusted provider of forecasting and commercial intelligence to the pharmaceutical industry. With a combination of gold standard data sources and deep pharma expertise, Evaluate helps clients make the right portfolio decisions to drive growth.
​
​Evaluate's solutions provide a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, underpinned by consensus forecasts to 2032, pipelines, deals and more. A consulting and analytics team is on always hand to help clients address unique clinical and commercial challenges.








.png)




